Breast Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Breast Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Aug 30, 2018

---

• Best Practices for Genomic Assay Testing in Early-Stage Breast Cancer: Clinical and Medicolegal Perspectives.  
  Seidman Andrew D et al. Population health management 2017 20(4) 252-254
• Cancer Screening  
  Recommendations for individual patients vary according to their level of risk, Jackson Labs, clinician education
• Companions or patients? The impact of family presence in genetic consultations for inherited breast cancer: Relational autonomy in practice.  
  Gilbar Roy et al. Bioethics 2018 Jul 32(6) 378-387
• Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance.  
  Gilbert Elizabeth et al. Annals of surgical oncology 2017 Oct 24(10) 3048-3054
• Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.  
  Abdel-Razeq Hikmat et al. BMC cancer 2018 18(1) 152
• Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System.  
  Marino Maria Adele et al. European journal of radiology 2018 Sep 106150-159
• Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers.  
  Choi Jonghwan et al. Bioinformatics (Oxford, England) 2017 Nov 33(22) 3619-3626
• Opinion: Consumer DNA Testing Is Crossing into Unethical Territories-Data don’t support many direct-to-consumer products, from telomere assessments to bespoke diets based on genetic sequences.  
  JD Loike, The Scientist, August 2018
• Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer.  
  Liu Xiawei et al. EBioMedicine 2018 Feb 2870-79
• Talazoparib for BRCA-mutated advanced breast cancer.  
  Gunjur Ashray et al. The Lancet. Oncology 2018 Aug